Company page
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. is a public company based in the United States, trading under the ticker AXSM. The company has a market capitalization of approximately $12.4 billion. Axsome focuses on developing innovative therapies for central nervous system disorders.
- Ticker
- AXSM:NASDAQ
- Asset type
- Stock
- Market cap
- $10.42B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD